Effective March 18, 2020, TRICARE eliminated all copays for USFHP members for SARS-CoV-2/COVID-19 FDA-approved diagnostic testing. Copays are waived when the visit results in a test or an order for a test.
This includes services and supplies used in the administration of a test or in the evaluation for a need for a Covid-19 test. It applies to services received in a USFHP provider’s office, an urgent care facility or an emergency room. This also includes telemedicine visits when they are conducted in accordance with TRICARE Policy.
Copayments and cost-shares for treatment of COVID-19 infection are not waived.